Announcements Trials

Browse Landscape

Status

Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 1 Advanced Breast Cancer 1

Interventions

Letrozole 2 Anastrozole 2 trastuzumab deruxtecan 1 dalpiciclib 1 Vinorelbine 1 Standard of Care 1 Safety 1 Radiotherapy 1 In Situ Hybridization, Fluorescence 1 Gonadotropin-Releasing Hormone 1 Aromatase Inhibitors 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Advanced Breast Cancer × Safety × Clear all

NCT06926088 2025-04-13

CAMELIA

The First Affiliated Hospital with Nanjing Medical University

Active not recruiting

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡